Microbot Medical Inc. (MBOT)
MBOT trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | MBOT on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | Israel |
| IPO year | Not reported by the screener |
| SEC CIK | 0000883975 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2015-12-31.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-13 |
| Cash and burn | $3.2M cash; operating cash flow -$4.4M a quarter. | Report 2026-06-30 |
| Shares outstanding | 67,164,801 (2026-11-12); 67,158,044 a year earlier; 11,707,317 three years earlier. | Cover page 2026-11-12 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2026-04-10 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Brightman Almagor Zohar & Co., Tel Aviv, Israel | PCAOB Form AP 2026-04-30 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $241K | -$5.6M | -$5.0M | $3.2M | No debt tags | Needs four quarters | 10-Q 2026-08-11 |
| Q1 2026 2026-03-31 | $105K | -$3.7M | -$5.1M | $3.7M | No debt tags | Needs four quarters | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | Not filed | -$3.5M | -$3.8M | $3.9M | No debt tags | Needs four quarters | 10-K 2026-03-26 |
| Q3 2025 2025-09-30 | Not filed | -$3.6M | -$3.8M | $6.7M | No debt tags | Needs four quarters | 10-Q 2025-11-12 |
| Q2 2025 2025-06-30 | Not filed | -$3.5M | -$2.6M | $4.1M | No debt tags | Needs four quarters | 10-Q 2026-08-11 |
| Q1 2025 2025-03-31 | Not filed | -$2.6M | -$2.9M | $3.2M | No debt tags | Needs four quarters | 10-Q 2026-08-11 |
| Q4 2024 2024-12-31 | Not filed | -$3.4M | -$1.7M | $3.1M | No debt tags | Needs four quarters | 10-K 2026-03-26 |
| Q3 2024 2024-09-30 | Not filed | -$3.2M | -$2.8M | $479K | No debt tags | Needs four quarters | 10-Q 2025-11-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-04-10 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report | 8-K | 2026-11-16 |
| Latest proxy | DEFA14A | 2026-11-03 |
Source: SEC EDGAR submissions feed, 1,007 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -11.7% |
| 1 month | -3.9% |
| 3 months | -41.7% |
| Year to date | -51.0% |
| 1 year | -50.8% |
| From 52-week high | -65.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ADGM | Adagio Medical Holdings Inc | $1.61 | -16.58% | $44.2M |
| MDAI | Spectral AI Inc. | $1.31 | +0.77% | $42.2M |
| SRTS | Sensus Healthcare Inc. | $2.34 | +0.65% | $38.5M |
| DXR | Daxor Corporation | $8.36 | -0.89% | $48.8M |
| TELA | TELA Bio Inc. | $0.7616 | -7.13% | $34.4M |
| NEPH | Nephros Inc. | $3.00 | -1.64% | $32.6M |
| XTNT | Xtant Medical Holdings Inc. | $0.2098 | -22.78% | $29.4M |
| QTEX | QTREX Quantum Ltd. | $1.15 | -8.00% | $64.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier